keyword
MENU ▼
Read by QxMD icon Read
search

Francais

keyword
https://www.readbyqxmd.com/read/29194022/r%C3%A3-sum%C3%A3-s-en-fran%C3%A3-ais
#1
(no author information available yet)
No abstract text is available yet for this article.
December 2017: Intellectual and Developmental Disabilities
https://www.readbyqxmd.com/read/29190507/results-of-methotrexate-etoposide-ifosfamide-based-regimen-m-ei-in-osteosarcoma-patients-included-in-the-french-os2006-sarcome-09-study
#2
Nathalie Gaspar, Bob-Valéry Occean, Hélène Pacquement, Emmanuelle Bompas, Corine Bouvier, Hervé J Brisse, Marie-Pierre Castex, Nadir Cheurfa, Nadège Corradini, Jessy Delaye, Natacha Entz-Werlé, Jean-Claude Gentet, Antoine Italiano, Cyril Lervat, Perrine Marec-Berard, Eric Mascard, Françoise Redini, Laure Saumet, Claudine Schmitt, Marie-Dominique Tabone, Cécile Verite-Goulard, Marie-Cécile Le Deley, Sophie Piperno-Neumann, Laurence Brugieres
BACKGROUND: In most countries, reference chemotherapy for osteosarcoma is MAP regimen (M = high-dose methotrexate, AP = doxorubicin-cisplatinum). In France, the standard preoperative chemotherapy for children/adolescents combines M and etoposide-ifosfamide (EI), based on the OS94-trial. We report the safety and efficacy results of patients ≤25 years treated with preoperative M-EI regimen enroled in the French OS2006-study, between 2007 and 2014. METHODS: Treatment comprised preoperative chemotherapy with the 7 M-courses and 2 EI-courses, then surgery and postoperative chemotherapy assigned by risk's groups: standard-risk (good histological response without metastases) received 12 M-courses, 3 EI-courses; high-risk (poor histologic response, initial metastases or unresectable primary) received 5 M-courses alternated with 5 AP-courses...
November 27, 2017: European Journal of Cancer
https://www.readbyqxmd.com/read/29144721/functionalized-solid-state-nanopore-integrated-in-a-reusable-microfluidic-device-for-a-better-stability-and-nanoparticle-detection
#3
Jean Roman, Nathalie Jarroux, Gilles Patriarche, Olivier Francais, Juan Pelta, Bruno Le Pioufle, Laurent Bacri
Electrical detection based on single nanopores is an efficient tool to detect biomolecules, particles and study their morphology. Nevertheless the surface of the solid-state supporting the nanopore should be better controlled. Moreover, nanopore should be integrated within microfluidic architecture to facilitate control fluid exchanges. We built a reusable microfluidic system integrating a decorated membrane into a fluidic circuit, rendering the drain or refill of analytes and buffers easier. This process enhances strongly ionic conductance of the nanopore and its life-time...
November 16, 2017: ACS Applied Materials & Interfaces
https://www.readbyqxmd.com/read/29115875/r%C3%A3-sum%C3%A3-s-en-fran%C3%A3-ais
#4
(no author information available yet)
No abstract text is available yet for this article.
November 2017: American Journal on Intellectual and Developmental Disabilities
https://www.readbyqxmd.com/read/29067906/the-age-of-blood-evaluation-able-randomised-controlled-trial-description-of-the-uk-funded-arm-of-the-international-trial-the-uk-cost-utility-analysis-and-secondary-analyses-exploring-factors-associated-with-health-related-quality-of-life-and-health-care-costs
#5
Timothy S Walsh, Simon Stanworth, Julia Boyd, David Hope, Sue Hemmatapour, Helen Burrows, Helen Campbell, Elena Pizzo, Nicholas Swart, Stephen Morris
BACKGROUND: At present, red blood cells (RBCs) are stored for up to 42 days prior to transfusion. The relative effectiveness and safety of different RBC storage times prior to transfusion is uncertain. OBJECTIVE: To assess the clinical effectiveness and cost-effectiveness of transfusing fresher RBCs (stored for ≤ 7 days) compared with current standard-aged RBCs in critically ill patients requiring blood transfusions. DESIGN: The international Age of BLood Evaluation (ABLE) trial was a multicentre, randomised, blinded trial undertaken in Canada, the UK, the Netherlands and France...
October 2017: Health Technology Assessment: HTA
https://www.readbyqxmd.com/read/29030147/-report-from-the-cfef-seminar-on-fetal-biometry-june-2017
#6
Collège Français d'échographie Fœtale Cfef
This article reports the conclusions and recommendations resulting from the seminar organized in Paris on June 15, 2017 by the scientific committee of the French College of Fetal Ultrasound (CFEF). The purpose of this meeting was to audit the practices in screening for SGA and IUGR fetuses in France and to discuss ways to improve ultrasound screening. A review of charts, references, standards and common practices was performed. The potential new biometric tools applicable in France were reviewed and analyzed...
October 10, 2017: Gynecologie, Obstetrique, Fertilite & Senologie
https://www.readbyqxmd.com/read/28972866/r%C3%A3-sum%C3%A3-s-en-fran%C3%A3-ais
#7
(no author information available yet)
No abstract text is available yet for this article.
October 2017: Intellectual and Developmental Disabilities
https://www.readbyqxmd.com/read/28846043/r%C3%A3-sum%C3%A3-s-en-fran%C3%A3-ais
#8
(no author information available yet)
No abstract text is available yet for this article.
September 2017: American Journal on Intellectual and Developmental Disabilities
https://www.readbyqxmd.com/read/28814348/traduction-fran%C3%A3-aise-de-l-%C3%A3-chelle-charcot-marie-tooth-disease-pediatric-scale
#9
Cynthia Gagnon, Rami Massie, Marjolaine Tremblay, Sylvie Darcy, Mélissa Martel, Joshua Burns
Résumé Cet article présente le processus de traduction en français du Charcot-Marie-Tooth Disease Pediatric Scale (CMTPedS), le seul outil de mesure validé évaluant la sévérité de la maladie chez les enfants atteints de CMT. Le processus de traduction utilisé s'inspire des lignes directrices de la Food and Drug Administration (FDA). La version préliminaire francophone du CMTPedS a été testée auprès de 14 enfants atteints. Les résultats de l'application démontrent que la passation a été bien tolérée par les enfants et s'est avérée conviviale pour les cliniciens...
August 17, 2017: Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques
https://www.readbyqxmd.com/read/28801186/interim-results-from-the-catnon-trial-eortc-study-26053-22054-of-treatment-with-concurrent-and-adjuvant-temozolomide-for-1p-19q-non-co-deleted-anaplastic-glioma-a-phase-3-randomised-open-label-intergroup-study
#10
Martin J van den Bent, Brigitta Baumert, Sara C Erridge, Michael A Vogelbaum, Anna K Nowak, Marc Sanson, Alba Ariela Brandes, Paul M Clement, Jean Francais Baurain, Warren P Mason, Helen Wheeler, Olivier L Chinot, Sanjeev Gill, Matthew Griffin, David G Brachman, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Jaap Reijneveld, Roelien H Enting, Damien C Weber, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, Sarah Pascoe, Ulrich Herrlinger, Peter Hau, Frederic Dhermain, Irene van Heuvel, Roger Stupp, Ken Aldape, Robert B Jenkins, Hendrikus Jan Dubbink, Winand N M Dinjens, Pieter Wesseling, Sarah Nuyens, Vassilis Golfinopoulos, Thierry Gorlia, Wolfgang Wick, Johan M Kros
BACKGROUND: The role of temozolomide chemotherapy in newly diagnosed 1p/19q non-co-deleted anaplastic gliomas, which are associated with lower sensitivity to chemotherapy and worse prognosis than 1p/19q co-deleted tumours, is unclear. We assessed the use of radiotherapy with concurrent and adjuvant temozolomide in adults with non-co-deleted anaplastic gliomas. METHODS: This was a phase 3, randomised, open-label study with a 2 × 2 factorial design. Eligible patients were aged 18 years or older and had newly diagnosed non-co-deleted anaplastic glioma with WHO performance status scores of 0-2...
October 7, 2017: Lancet
https://www.readbyqxmd.com/read/28753405/r%C3%A3-sum%C3%A3-s-en-fran%C3%A3-ais
#11
(no author information available yet)
No abstract text is available yet for this article.
July 2017: Intellectual and Developmental Disabilities
https://www.readbyqxmd.com/read/28675357/the-european-policy-for-liver-allocation-in-patients-affected-by-hepatocellular-carcinoma
#12
REVIEW
Stefano Di Sandro, Fabio Ferla, Andrea Lauterio, Iacopo Mangoni, Riccardo De Carlis, Vincenzo Buscemi, Luciano De Carlis
The main goal of allocation system is to guarantee an equal access to the limited resource of liver grafts for every class of patients on the waiting list, balancing between the ethical principles of equity, utility, benefit, need, and fairness. The aim of this review was to analyze liver allocation policies among these organizations, focusing on HCC. The European area considered for this analysis included 6 macro-areas or countries, which are congregated from the same policy of liver sharing and allocation...
May 2017: Chirurgia
https://www.readbyqxmd.com/read/28654415/r%C3%A3-sum%C3%A3-s-en-fran%C3%A3-ais
#13
(no author information available yet)
No abstract text is available yet for this article.
July 2017: American Journal on Intellectual and Developmental Disabilities
https://www.readbyqxmd.com/read/28608775/r%C3%A3-sum%C3%A3-s-en-fran%C3%A3-ais
#14
(no author information available yet)
No abstract text is available yet for this article.
June 2017: Intellectual and Developmental Disabilities
https://www.readbyqxmd.com/read/28608361/using-poisson-gamma-model-to-evaluate-the-duration-of-recruitment-process-when-historical-trials-are-available
#15
Nathan Minois, Valérie Lauwers-Cances, Stéphanie Savy, Michel Attal, Sandrine Andrieu, Vladimir Anisimov, Nicolas Savy
At the design of clinical trial operation, a question of a paramount interest is how long it takes to recruit a given number of patients. Modelling the recruitment dynamics is the necessary step to answer this question. Poisson-gamma model provides very convenient, flexible and realistic approach. This model allows predicting the trial duration using data collected at an interim time with very good accuracy. A natural question arises: how to evaluate the parameters of recruitment model before the trial begins? The question is harder to handle as there are no recruitment data available for this trial...
June 12, 2017: Statistics in Medicine
https://www.readbyqxmd.com/read/28506877/clinical-practice-guidelines-synthesis-of-the-guidelines-for-the-surgical-treatment-of-primary-pelvic-organ-prolapse-in-women-by-the-afu-cngof-sifud-pp-snfcp-and-scgp
#16
L Le Normand, M Cosson, F Cour, X Deffieux, L Donon, P Ferry, B Fatton, J-F Hermieu, H Marret, G Meurette, A Cortesse, L Wagner, X Fritel
No abstract text is available yet for this article.
May 2017: Journal of Gynecology Obstetrics and Human Reproduction
https://www.readbyqxmd.com/read/28473952/liver-allocation-policies-for-patients-affected-by-hcc-in-europe
#17
Luciano De Carlis, Stefano Di Sandro, Leonardo Centonze, Andrea Lauterio, Vincenzo Buscemi, Riccardo De Carlis, Fabio Ferla, Raffaella Sguinzi, Stefano Okolicsanyi, Luca Belli, Mario Strazzabosco
The main goal of organ allocation systems is to guarantee an equal access to the limited resource of liver grafts for every patients on the waiting list, balancing between the ethical principles of equity, utility, benefit, need, and fairness. The European heath care scenario is very complex, as it is essentially decentralized and each Nation and Regions inside the nation, operate on a significant degree of autonomy. Furthermore the epidemiology of liver diseases and HCC, which is different among European countries, clearly inpacts on indications and priorities...
December 2016: Current Transplantation Reports
https://www.readbyqxmd.com/read/28457680/-hypocomplementemic-urticarial-vasculitis
#18
M Jachiet, B Flageul, J-D Bouaziz, M Bagot, B Terrier
Hypocomplementemic urticarial vasculitis (HUV), called anti-C1q vasculitis in the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, is a rare systemic vasculitis of unknown etiology, affecting small vessels. HUV is characterized by urticarial lesions, hypocomplementemia and systemic manifestations, mostly musculoskeletal and ocular, but also gastrointestinal, pulmonary and kidney involvement. Anti-C1q antibodies are detected in only half of the patients, and low C1q seems to represent a more sensitive marker...
April 27, 2017: La Revue de Médecine Interne
https://www.readbyqxmd.com/read/28452580/r%C3%A3-sum%C3%A3-s-en-fran%C3%A3-ais
#19
(no author information available yet)
No abstract text is available yet for this article.
May 2017: American Journal on Intellectual and Developmental Disabilities
https://www.readbyqxmd.com/read/28375800/r%C3%A3-sum%C3%A3-s-en-fran%C3%A3-ais
#20
(no author information available yet)
No abstract text is available yet for this article.
April 2017: Intellectual and Developmental Disabilities
keyword
keyword
1861
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"